Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Maximizing the potency of oxaliplatin coated nanoparticles with folic acid for modulating tumor progression in colorectal cancer.
Oliveira ALCSL, Zerillo L, Cruz LJ, Schomann T, Chan AB, de Carvalho TG, Souza SVP, Araújo AA, de Geus-Oei LF, de Araújo Júnior RF. Oliveira ALCSL, et al. Among authors: cruz lj. Mater Sci Eng C Mater Biol Appl. 2021 Jan;120:111678. doi: 10.1016/j.msec.2020.111678. Epub 2020 Oct 27. Mater Sci Eng C Mater Biol Appl. 2021. PMID: 33545840 Free article.
Nanocarriers as a Tool for the Treatment of Colorectal Cancer.
C de S L Oliveira AL, Schomann T, de Geus-Oei LF, Kapiteijn E, Cruz LJ, de Araújo Junior RF. C de S L Oliveira AL, et al. Among authors: cruz lj. Pharmaceutics. 2021 Aug 23;13(8):1321. doi: 10.3390/pharmaceutics13081321. Pharmaceutics. 2021. PMID: 34452282 Free PMC article. Review.
Extracellular Vesicles from M1-Polarized Macrophages Combined with Hyaluronic Acid and a β-Blocker Potentiate Doxorubicin's Antitumor Activity by Downregulating Tumor-Associated Macrophages in Breast Cancer.
Jorquera-Cordero C, Lara P, Cruz LJ, Schomann T, van Hofslot A, de Carvalho TG, Guedes PMDM, Creemers L, Koning RI, Chan AB, de Araujo Junior RF. Jorquera-Cordero C, et al. Among authors: cruz lj. Pharmaceutics. 2022 May 17;14(5):1068. doi: 10.3390/pharmaceutics14051068. Pharmaceutics. 2022. PMID: 35631654 Free PMC article.
STAT3/NF-κB signalling disruption in M2 tumour-associated macrophages is a major target of PLGA nanocarriers/PD-L1 antibody immunomodulatory therapy in breast cancer.
Cavalcante RS, Ishikawa U, Silva ES, Silva-Júnior AA, Araújo AA, Cruz LJ, Chan AB, de Araújo Júnior RF. Cavalcante RS, et al. Among authors: cruz lj. Br J Pharmacol. 2021 Jun;178(11):2284-2304. doi: 10.1111/bph.15373. Epub 2021 Mar 31. Br J Pharmacol. 2021. PMID: 33434950 Free PMC article.
217 results